Stanley Capital

Stanley Capital is a private equity investment firm based in London, United Kingdom, founded in 2019. The firm specializes in pursuing repeatable relative value and thematic investment strategies, focusing on sectors such as technology, healthcare, and sustainability. By targeting businesses within these industries, Stanley Capital aims to drive growth and create value through its investment initiatives across Europe.

James Brooks

Founding Partner

Simon Cottle

Founding Partner

Patrick Hargutt

Founding Partner

3 past transactions

SePRO

Acquisition in 2024
SePRO Corporation is a manufacturer specializing in plant protection and management products tailored for various sectors, including aquatics, agriculture, landscape, ornamental, golf, and DIY aquatics. The company develops sustainable agriculture-based specialty chemicals, offering a range of products such as plant growth regulators, herbicides, insecticides, and fungicides. These products are designed to assist professionals in managing invasive weeds and algae in both terrestrial and aquatic environments, thereby supporting effective crop management and environmental sustainability. SePRO's focus on innovation in agricultural chemicals positions it as a key player in the market.

Roboyo

Private Equity Round in 2023
Founded in 2015, Roboyo is a global leader in intelligent automation consulting. With operations across four continents, it serves Fortune 500 companies and DAX 40 enterprises. Roboyo specializes in robotic process automation, artificial intelligence, and hyperautomation, serving industries such as manufacturing, finance, pharmaceuticals, and consumer goods.

Noden Pharma

Acquisition in 2020
Noden Pharma is a global specialty pharmaceutical company dedicated to acquiring and marketing prescription medicines across various therapeutic areas. The company holds exclusive worldwide rights to manufacture, market, and sell Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor used in the treatment of hypertension. By focusing on international markets, Noden Pharma aims to enhance the quality of life for patients through its specialized medical solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.